MedTrace Logo

Detecting Clinically Significant Prostate Cancer With Advanced MRI Protocols and Extensive Histopathology

NCT07432360 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2026-02-25

No results posted yet for this study

Summary

In recent years, new and promising approaches have emerged in the field of MRI imaging of the prostate. These approaches usually aim to visualise the so-called "microstructures" of the tissue and are intended to offer greater accuracy in the diagnosis of prostate cancer than the current mpMRI examination. To this end, mathematical microstructure models are calculated that determine the proportional presence of histological substructures in specific MRI volumes. Additional new MRI sequences that are not routinely recorded are required to calculate the microstructure models. In order to further investigate the possibilities of these new MRI sequences, this study will compare different mathematical models. In addition, a histopathological examination of the tissue will be performed.

Conditions

Sponsors & Collaborators

  • Instituto do Cancer do Estado de São Paulo

    collaborator OTHER

  • Virdx, Inc.

    lead INDUSTRY

Principal Investigators

  • Marcelo Araujo Queiroz, MD PhD · Instituto do Câncer do Estado de São Paulo

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-28
Primary Completion
2028-06-30
Completion
2028-06-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07432360 on ClinicalTrials.gov